trending Market Intelligence /marketintelligence/en/news-insights/trending/xmnvjjpfh4l22oisj9lxvq2 content esgSubNav
In This List

Vaxil appoints CEO

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Vaxil appoints CEO

Israel-based Vaxil Bio Ltd. appointed David Goren CEO and board member.

Goren previously held senior positions at drugmakers Pfizer Inc. and AstraZeneca PLC.

Vaxil develops and sells immunotherapies for cancer and other diseases in Israel.